Sanofi Operating Cycle 2011-2025 | SNY

Annual Operating Cycle Sanofi

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	330	311	314	308	307	286

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
330	286	309

Operating Cycle of other stocks in the Biotechnology industry

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Aptevo Therapeutics APVO	191	$ 0.58	-3.71 %	$ 160 K	USA
Aclaris Therapeutics ACRS	6.01	$ 3.03	-	$ 234 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	12	$ 1.11	-2.63 %	$ 6.05 M	China
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	349	-	-7.31 %	$ 87 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Catalyst Biosciences CBIO	410	$ 12.36	0.08 %	$ 814 M	USA
Amphastar Pharmaceuticals AMPH	195	$ 26.84	-1.03 %	$ 1.3 B	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Anika Therapeutics ANIK	325	$ 9.52	-0.37 %	$ 140 M	USA
Certara CERT	88.6	$ 8.86	-0.39 %	$ 1.42 B	USA
bluebird bio BLUE	127	-	-	$ 546 M	USA
Cellectis S.A. CLLS	136	$ 4.9	3.16 %	$ 116 M	France
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	116	$ 580.39	-0.59 %	$ 44 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	360	$ 2.57	4.7 %	$ 16.1 M	USA
AstraZeneca PLC AZN	206	$ 92.75	-0.16 %	$ 96.9 B	Britain
ChromaDex Corporation CDXC	114	-	-0.88 %	$ 598 M	USA
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
Celldex Therapeutics CLDX	86.5	$ 26.14	-0.98 %	$ 1.68 M	USA